DrugsControl Media Services
DrugsControl.org

News Detail

Over 60% FDCs used for mental illnesses in India unapproved by apex regulator, finds study (29-08-2024)

New Delhi, 29 Aug 2024: Over 60 percent fixed-dose combination (FDC) drugs consumed for mental health disorders in India are “unapproved” and lack therapeutic benefit, an analysis has found amid a major crackdown on FDC drugs by the country’s apex drug regulator......
View Details

Source : The Print
fixed-dose combination (FDC) mental health disorders unapproved Journal of Pharmaceutical Policy and Practice Fixed dose combination psychiatry psychotropic psychopharmacology pharmacoepidemiology India

Related News